Free Trial

Cerevel Therapeutics (CERE) News Today

→ No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad)
Free CERE Stock Alerts
$40.08
+0.06 (+0.15%)
(As of 10:49 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrends
June 9 at 8:55 AM | marketbeat.com
Water Island Capital LLC Buys New Stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Water Island Capital LLC purchased a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 588,100 shares of the biotechnology company's stock, valued at approximately
June 8 at 5:12 AM | globenewswire.com
CEREVEL NEWS NOTIFICATION: BFA Law Alerts Cerevel (Nasdaq: CERE) Shareholders of Investigation into the $45 Merger Offer, Contact the Firm About Your Rights
June 7 at 6:55 PM | marketbeat.com
Bain Capital Investors LLC Has $2.78 Billion Stock Holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Bain Capital Investors LLC lifted its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 65,679,781 shares of the biotechnology company's stock after pur
June 6, 2024 | marketbeat.com
GABELLI & Co INVESTMENT ADVISERS INC. Invests $11.68 Million in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 275,500 shares of the biotechnology company's sto
June 5, 2024 | globenewswire.com
CEREVEL INVESTIGATION ALERT: Cerevel (Nasdaq: CERE) Investors are Encouraged to Contact BFA Law about the $45 Merger Offer from AbbVie
June 5, 2024 | marketbeat.com
Lake Street Advisors Group LLC Has $10.36 Million Stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Lake Street Advisors Group LLC grew its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 191.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 244,309 shares of the biotechnology company's
June 4, 2024 | marketbeat.com
Carmignac Gestion Purchases Shares of 44,181 Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Carmignac Gestion acquired a new position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 44,181 shares of the biotechnology company's stock, valued at app
June 4, 2024 | seekingalpha.com
Cerevel Therapeutics: Time For A Risk Arbitrage Play?
June 3, 2024 | globenewswire.com
ACQUISITION NEWS: Cerevel's (Nasdaq: CERE) $45 Merger Offer is Being Investigated for Being Too Low, Shareholders are Encouraged Contact BFA Law
June 2, 2024 | marketbeat.com
Short Interest in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Grows By 7.7%
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 7,110,000 shares, a growth of 7.7% from the April 30th total of 6,600,000 shares. Based on an average daily volume of 1,150,000 shares, the short-interest ratio is presently 6.2 days. Approximately 8.1% of the shares of the stock are sold short.
June 2, 2024 | marketbeat.com
408,032 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC acquired a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 408,032 shares of the biotechnology company's stock, valued at approximately $17,321,00
June 1, 2024 | marketbeat.com
Norges Bank Makes New $29.07 Million Investment in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Norges Bank acquired a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 685,694 shares of the biotechnology company's
May 30, 2024 | marketbeat.com
Olympiad Research LP Invests $2.01 Million in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Olympiad Research LP acquired a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 47,304 shares of the biotechnology company's stock, valued at appr
May 30, 2024 | prnewswire.com
CEREVEL INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm
May 29, 2024 | finance.yahoo.com
Pipeline for Acquisition Financing Shrinks, in Boon for Credit
May 29, 2024 | businesswire.com
Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
May 26, 2024 | marketbeat.com
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Sold by Westfield Capital Management Co. LP
Westfield Capital Management Co. LP decreased its holdings in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 19.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 785,494 shares of the biotechnology company's
May 23, 2024 | marketbeat.com
Charles Schwab Investment Management Inc. Grows Stock Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Charles Schwab Investment Management Inc. lifted its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 25.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 649,333 shares of the biot
May 20, 2024 | marketbeat.com
180,000 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Purchased by Kapitalo Investimentos Ltda
Kapitalo Investimentos Ltda acquired a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 180,000 sh
May 20, 2024 | prnewswire.com
NOTICE OF INVESTIGATION: Kaskela Law LLC Announces Shareholder Investigation of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) and Encourages Investors to Contact the Firm
May 20, 2024 | markets.businessinsider.com
Analysts Conflicted on These Healthcare Names: Cerevel Therapeutics Holdings (CERE), Cullinan Management (CGEM) and Vincerx Pharma Inc (VINC)
May 19, 2024 | morningstar.com
Cerevel Therapeutics Holdings Inc Ordinary Shares CERE
May 18, 2024 | stockhouse.com
BFA LLP Reminds Cerevel Therapeutics Shareholders of the Investigation into Merger with AbbVie and Encourages Investors to Contact the Firm
May 16, 2024 | insidertrades.com
N Anthony Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Stock
May 15, 2024 | stockhouse.com
MERGER ALERT CERE Is $45 per CERE Share Fair? Top Law Firm BFA LLP Investigating Cerevel Therapeutics Merger with AbbVie
May 15, 2024 | insidertrades.com
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director Sells $2,105,000.00 in Stock
May 14, 2024 | marketbeat.com
Insider Selling: Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Director Sells 50,000 Shares of Stock
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) Director N Anthony Coles sold 50,000 shares of the company's stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $42.10, for a total value of $2,105,000.00. Following the sale, the director now owns 15,638 shares in the company, valued at approximately $658,359.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
May 11, 2024 | marketbeat.com
108,657 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Purchased by Versor Investments LP
Versor Investments LP bought a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 108,657 shares of the biotechnol
May 10, 2024 | marketbeat.com
Kellner Capital LLC Invests $861,000 in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Kellner Capital LLC bought a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 20,300 shares of the biotechnology company's stock, valued at app
May 9, 2024 | marketbeat.com
Segantii Capital Management Ltd Buys Shares of 594,519 Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Segantii Capital Management Ltd purchased a new stake in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 594,519 shares of the biotechnology compa
May 6, 2024 | marketbeat.com
BCK Capital Management LP Makes New Investment in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
BCK Capital Management LP bought a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 22,000 shares of the biotechnology company's stock, valued at approximately $933,
May 5, 2024 | marketbeat.com
International Assets Investment Management LLC Purchases Shares of 55,120 Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
International Assets Investment Management LLC acquired a new position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 55,120 shares of the biotechnology co
April 30, 2024 | finance.yahoo.com
Addex stock tanks after lead drug flops in Phase II epilepsy trial
April 26, 2024 | finance.yahoo.com
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
April 22, 2024 | markets.businessinsider.com
Hold Rating Maintained for Cerevel Post-Positive Phase 3 Data Amid Pending AbbVie Acquisition
April 20, 2024 | marketbeat.com
Calamos Advisors LLC Makes New Investment in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Calamos Advisors LLC purchased a new position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 305,303 shares of the biotechnology company's stock, val
April 18, 2024 | benzinga.com
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
April 18, 2024 | msn.com
AbbVie buyout Cerevel posts late-stage win for Parkinson’s disease drug
April 18, 2024 | reuters.com
Cerevel Therapeutics' Parkinson's disease drug meets main goal in late-stage study
April 18, 2024 | finance.yahoo.com
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
April 18, 2024 | globenewswire.com
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
April 16, 2024 | markets.businessinsider.com
Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI) and Unity Biotechnology (UBX)
April 12, 2024 | marketbeat.com
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Short Interest Up 38.2% in March
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 9,620,000 shares, a growth of 38.2% from the March 15th total of 6,960,000 shares. Based on an average daily trading volume, of 1,510,000 shares, the short-interest ratio is currently 6.4 days. Approximately 11.1% of the company's shares are sold short.
April 12, 2024 | seekingalpha.com
AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67%
April 11, 2024 | marketbeat.com
International Assets Investment Management LLC Takes Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
International Assets Investment Management LLC purchased a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 55,120
April 5, 2024 | investing.com
Cerevel Therapeutics director sells $2.12m in stock, buys $175k worth
April 3, 2024 | uk.finance.yahoo.com
Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)
April 3, 2024 | marketbeat.com
Vanguard Group Inc. Purchases 708,826 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)
Vanguard Group Inc. increased its position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) by 12.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,371,376 shares of the biotechnology company's stock
March 31, 2024 | marketbeat.com
24,487 Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Acquired by SG Americas Securities LLC
SG Americas Securities LLC bought a new stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 24,487 shares of the biotechnology c
March 29, 2024 | wsj.com
Cerevel Therapeutics Holdings Inc.
Get Cerevel Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter.

No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)

Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!

TRY "INVESTING IDEAS" TODAY

CERE Media Mentions By Week

CERE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CERE
News Sentiment
▼
0.52

0.76
▲
Average
Medical
News Sentiment

CERE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CERE Articles
This Week
▼
9

3
▲
CERE Articles
Average Week

Get Cerevel Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CERE) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
The #1 Crypto That You Don’t Own… Yet
There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...
Crypto 101 Media | Sponsored
Prepare for a Recession Unlike Any Other
Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...
American Hartford Gold Group | Sponsored
Trump convicted... now what?
Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...
Stansberry Research | Sponsored
It's time to ween off Chinese lithium!
As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...
Smallcaps Daily | Sponsored
Time is Running Out - June 25th Deadline Approaching!
Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...
Paradigm Press | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored